FFTinvolves family members in the treatment process of people with bipolar disorder. It helps educate family members about the condition, improves communication, and reduces conflicts that can ...
The U.S. Food and Drug Administration in 2019 approved intranasal esketamine to treat depression in adults. However, little data is available on the use of ketamine or esketamine to treat bipolar ...
According to Research by , The Antipsychotic Drugs Market is Expected to Grow at a CAGR of 6.53% Through 2032, Supported by Increasing Prevalence of Psychotic Disorders, Advancements in Medication ...
Still, several myths ... New Home-Administered Treatment for Binge Eating Disorder Shows Promising Results June 6, 2024 — Researchers have investigated the feasibility of a new home-administered ...